Utility of insulin-like growth factor-1 as a biomarker in epidemiologic studies.

Clin Chem

Orentreich Foundation for the Advancement of Science, Inc., 855 Route 301, Cold Spring-on-Hudson, NY 10516, USA.

Published: December 2002

Download full-text PDF

Source

Publication Analysis

Top Keywords

utility insulin-like
4
insulin-like growth
4
growth factor-1
4
factor-1 biomarker
4
biomarker epidemiologic
4
epidemiologic studies
4
utility
1
growth
1
factor-1
1
biomarker
1

Similar Publications

Background: Abnormal brain insulin signaling has been associated with Alzheimer's disease pathology and a faster rate of late-life cognitive decline. However, the underlying mechanisms remain unclear. In this study, we examined whether AD-related cortical proteins identified using targeted-proteomics play a role in the association of brain insulin signaling and cognitive decline.

View Article and Find Full Text PDF

Integrin αvβ3, a primary cell-adhesion receptor, plays a crucial role in various biological processes, including angiogenesis, pathological neovascularization, and tumor metastasis. Its expression increases during tumor angiogenesis. The insulin-like growth factor 1 receptor (IGF1R) is a transmembrane protein that stimulates vital signaling pathways, promoting cancer cell growth, survival, and metabolism.

View Article and Find Full Text PDF

Background: Acromegaly is a disease with high morbidity and mortality rates. The role of primary care physicians is very important in the early diagnosis of acromegaly. The present study aims to determine the knowledge and attitudes of primary care physicians about acromegaly in different countries worldwide.

View Article and Find Full Text PDF

Plasma biomarkers in patients with age-related sarcopenia: a proteomic exploration and experimental validation.

Aging Clin Exp Res

December 2024

Department of Geriatric Gastroenterology, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China.

Background: Various biomarkers associated with sarcopenia have been identified. However, there is a scarcity of studies exploring and validating biomarkers in individuals with age-related sarcopenia.

Aims: This study aimed to investigate the proteome and identify potential biomarkers for age-related sarcopenia.

View Article and Find Full Text PDF

An expert consensus statement on biomarkers of ageing for use in intervention studies.

J Gerontol A Biol Sci Med Sci

December 2024

Human Nutrition & Exercise Research Centre, Centre for Healthier Lives, Population Health Sciences Institute, Newcastle University, Newcastle Upon Tyne, UK.

Biomarkers of ageing serve as important outcome measures in longevity-promoting interventions. However, there is limited consensus on which specific biomarkers are most appropriate for human intervention studies. This work aimed to address this need by establishing an expert consensus on biomarkers of ageing for use in intervention studies via the Delphi method.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!